Figure 1.
Overall and progression free survival of DLBCL subtypes as assigned by Lymph2Cx according to BCL2 and MYC protein status.

Overall and progression free survival of DLBCL subtypes as assigned by Lymph2Cx according to BCL2 and MYC protein status.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal